EUVIMEDEUVIMED entdecken
Open Access

HOCl-producing electrochemical bandage for treating Pseudomonas aeruginosa -infected murine wounds

Derek Fleming iD, Ibrahim Bozyel, Dilara Ozdemir, Judith Alvarez Otero, Melissa J Karau, Md Monzurul Islam Anoy, Christina Koscianski, Audrey N Schuetz iD, Kerryl E Greenwood-Quaintance, Jayawant N Mandrekar, Haluk Beyenal, Robin Patel iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.01216-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Derek Fleming und 11 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic, Division of Clinical Microbiology, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Pseudomonas Infections, Wound Infection. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growing threat of antibiotic-resistant bacterial pathogens necessitates the development of alternative antimicrobial approaches. This is particularly true for chronic wound infections, which commonly harbor biofilm-dwelling bacteria. A novel electrochemical bandage (e-bandage) delivering low-levels of hypochlorous acid (HOCl) was evaluated against Pseudomonas aeruginosa murine wound biofilms. 5 mm skin wounds were created on the dorsum of mice and infected with 10 6 colony-forming units (CFU) of P. aeruginosa . Biofilms were formed over 2 days, after which e-bandages were placed on the wound beds and covered with Tegaderm. Mice were administered Tegaderm-only (control), non-polarized e-bandage (no HOCl production), or polarized e-bandage (using an HOCl-producing potentiostat), with or without systemic amikacin. Purulence and wound areas were measured before and after treatment. After 48 hours, wounds were harvested for bacterial quantification. Forty-eight hours of polarized e-bandage treatment resulted in mean biofilm reductions of 1.4 log 10 CFUs/g ( P = 0.0107) vs non-polarized controls and 2.2 log 10 CFU/g ( P = 0.004) vs Tegaderm-only controls. Amikacin improved CFU reduction in Tegaderm-only ( P = 0.0045) and non-polarized control groups ( P = 0.0312) but not in the polarized group ( P = 0.3876). Compared to the Tegaderm-only group, there was less purulence in the polarized group ( P = 0.009). Wound closure was neither impeded nor improved by either polarized or non-polarized e-bandage treatment. Concurrent amikacin did not impact wound closure or purulence. In conclusion, an HOCl-producing e-bandage reduced P. aeruginosa in wound biofilms with no impairment in wound healing, representing a promising antibiotic-free approach for addressing wound infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas InfectionsWound InfectionAnimalsMicePseudomonas aeruginosaHypochlorous AcidAmikacinBandagesAnti-Bacterial AgentsBiofilms

Stichwörter der Autor:innen

Pseudomonas aeruginosaanti-biofilmelectrochemical bandagehypochlorous acidin vivo wound infection

Substanzen

Hypochlorous AcidAmikacinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Mayo Clinic, Division of Clinical Microbiology, Rochester, Minnesota, USA.
  • The Gene and Linda Voiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, Washington, USA.
  • Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Derek Fleming, Audrey N Schuetz, Robin Patel

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Fleming, D., Bozyel, I., Ozdemir, D., Otero, J. A., Karau, M. J., Anoy, M. M. I., Koscianski, C., Schuetz, A. N., Greenwood-Quaintance, K. E., Mandrekar, J. N., Beyenal, H., & Patel, R. (2024). HOCl-producing electrochemical bandage for treating Pseudomonas aeruginosa -infected murine wounds. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01216-23

Vancouver

Fleming D, Bozyel I, Ozdemir D, Otero JA, Karau MJ, Anoy MMI, et al. HOCl-producing electrochemical bandage for treating Pseudomonas aeruginosa -infected murine wounds. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01216-23

BibTeX
@article{Fleming2024,
  author = {Fleming, Derek and Bozyel, Ibrahim and Ozdemir, Dilara and Otero, Judith Alvarez and Karau, Melissa J and Anoy, Md Monzurul Islam and Koscianski, Christina and Schuetz, Audrey N and Greenwood-Quaintance, Kerryl E and Mandrekar, Jayawant N and Beyenal, Haluk and Patel, Robin},
  title = {HOCl-producing electrochemical bandage for treating Pseudomonas aeruginosa -infected murine wounds},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.01216-23}
}
Kostenlos starten →